Certain Common Shares of ImmunoPrecise Antibodies Ltd. are subject to a Lock-Up Agreement Ending on 6-MAR-2024. These Common Shares will be under lockup for 91 days starting from 6-DEC-2023 to 6-MAR-2024.

Details:
The officers, directors, and holders of 5% of outstanding Common Shares, have agreed, subject to certain exceptions, that, during a period of 90 days after the date of this Prospectus Supplement, they will not sell, transfer or dispose of, directly or indirectly, any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares.